APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Weight Loss and Obesity Management

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Weight Loss and Obesity Management Market Outlook and Growth Opportunities 2026

Report ID 174047380420 December 2025194 pages

Choose your research edition.

Industry ResearchWeight Loss and Obesity Management Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Weight Loss and Obesity Management Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Weight Loss and Obesity Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Weight Loss and Obesity Management Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Weight Loss and Obesity Management Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Weight Loss and Obesity Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Weight Loss and Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Weight Loss and Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Weight Loss and Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Weight Loss and Obesity Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Weight Loss and Obesity Management market include Eisai, Johnson & Johnson, Novo Nordisk, Medtronic, Roche, GlaxoSmithKline, Vivus Inc, ReShape Lifesciences and Obalon Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Weight Loss and Obesity Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Weight Loss and Obesity Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Weight Loss and Obesity Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Weight Loss and Obesity Management market.

Weight Loss and Obesity Management Segment by Company

Eisai

Johnson & Johnson

Novo Nordisk

Medtronic

Roche

GlaxoSmithKline

Vivus Inc

ReShape Lifesciences

Obalon Therapeutics

Nalpropion Pharmaceuticals

Beijing Noble Laser Technology

Allurion Technologies

Allergan

Weight Loss and Obesity Management Segment by Type

Weight Loss and Obesity Management Devices

Weight Loss and Obesity Management Drugs

Weight Loss and Obesity Management Segment by Application

Men

Women

Weight Loss and Obesity Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Weight Loss and Obesity Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Weight Loss and Obesity Management key companies, revenue, market share, and recent developments.

3. To split the Weight Loss and Obesity Management breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Weight Loss and Obesity Management market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Weight Loss and Obesity Management significant trends, drivers, influence factors in global and regions.

6. To analyze Weight Loss and Obesity Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight Loss and Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Weight Loss and Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight Loss and Obesity Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Weight Loss and Obesity Management industry.

Chapter 3: Detailed analysis of Weight Loss and Obesity Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Weight Loss and Obesity Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Weight Loss and Obesity Management in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Weight Loss and Obesity Management Industry Trends Table 2. Weight Loss and Obesity Management Industry Drivers Table 3. Weight Loss and Obesity Management Industry Opportunities and Challenges Table 4. Weight Loss and Obesity Management Industry Restraints Table 5. Global Weight Loss and Obesity Management Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Weight Loss and Obesity Management Revenue Share by Company (2021-2026) Table 7. Global Weight Loss and Obesity Management Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Weight Loss and Obesity Management Key Company Manufacturing Base & Headquarters Table 9. Global Weight Loss and Obesity Management Company, Product Type & Application Table 10. Global Weight Loss and Obesity Management Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Weight Loss and Obesity Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Weight Loss and Obesity Management Devices Table 15. Significant Companies of Weight Loss and Obesity Management Drugs Table 16. Global Weight Loss and Obesity Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Weight Loss and Obesity Management Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Weight Loss and Obesity Management Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Weight Loss and Obesity Management Sales Value Share by Type (2021-2026) Table 20. Global Weight Loss and Obesity Management Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Men Table 22. Significant Companies of Women Table 23. Global Weight Loss and Obesity Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Weight Loss and Obesity Management Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Weight Loss and Obesity Management Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Weight Loss and Obesity Management Sales Value Share by Application (2021-2026) Table 27. Global Weight Loss and Obesity Management Sales Value Share by Application (2027-2032) Table 28. Global Weight Loss and Obesity Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Weight Loss and Obesity Management Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Weight Loss and Obesity Management Sales Value Share by Region (2021-2026) Table 31. Global Weight Loss and Obesity Management Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Weight Loss and Obesity Management Sales Value Share by Region (2027-2032) Table 33. Global Weight Loss and Obesity Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Weight Loss and Obesity Management Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Weight Loss and Obesity Management Sales Value Market Share by Country (2021-2026) Table 36. Global Weight Loss and Obesity Management Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Weight Loss and Obesity Management Sales Value Market Share by Country (2027-2032) Table 38. Eisai Company Information Table 39. Eisai Business Overview Table 40. Eisai Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Eisai Weight Loss and Obesity Management Product Portfolio Table 42. Eisai Recent Development Table 43. Johnson & Johnson Company Information Table 44. Johnson & Johnson Business Overview Table 45. Johnson & Johnson Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Johnson & Johnson Weight Loss and Obesity Management Product Portfolio Table 47. Johnson & Johnson Recent Development Table 48. Novo Nordisk Company Information Table 49. Novo Nordisk Business Overview Table 50. Novo Nordisk Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Novo Nordisk Weight Loss and Obesity Management Product Portfolio Table 52. Novo Nordisk Recent Development Table 53. Medtronic Company Information Table 54. Medtronic Business Overview Table 55. Medtronic Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Medtronic Weight Loss and Obesity Management Product Portfolio Table 57. Medtronic Recent Development Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Roche Weight Loss and Obesity Management Product Portfolio Table 62. Roche Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Weight Loss and Obesity Management Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. Vivus Inc Company Information Table 69. Vivus Inc Business Overview Table 70. Vivus Inc Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Vivus Inc Weight Loss and Obesity Management Product Portfolio Table 72. Vivus Inc Recent Development Table 73. ReShape Lifesciences Company Information Table 74. ReShape Lifesciences Business Overview Table 75. ReShape Lifesciences Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. ReShape Lifesciences Weight Loss and Obesity Management Product Portfolio Table 77. ReShape Lifesciences Recent Development Table 78. Obalon Therapeutics Company Information Table 79. Obalon Therapeutics Business Overview Table 80. Obalon Therapeutics Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Obalon Therapeutics Weight Loss and Obesity Management Product Portfolio Table 82. Obalon Therapeutics Recent Development Table 83. Nalpropion Pharmaceuticals Company Information Table 84. Nalpropion Pharmaceuticals Business Overview Table 85. Nalpropion Pharmaceuticals Weight Loss and Obesity Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Nalpropion Pharmaceuticals Weight Loss and Obesity Management Product Portfolio Table 87. Nalpropion Pharmaceuticals Recent Development Table 88. Beijing Noble Laser Technology Company Information Table 89. Beijing Noble Laser Technology Business Overview Table 90. Beijing Noble Laser Technology Weight Loss and Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Beijing Noble Laser Technology Weight Loss and Obesity Management Product Portfolio Table 92. Beijing Noble Laser Technology Recent Development Table 93. Allurion Technologies Company Information Table 94. Allurion Technologies Business Overview Table 95. Allurion Technologies Weight Loss and Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Allurion Technologies Weight Loss and Obesity Management Product Portfolio Table 97. Allurion Technologies Recent Development Table 98. Allergan Company Information Table 99. Allergan Business Overview Table 100. Allergan Weight Loss and Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Allergan Weight Loss and Obesity Management Product Portfolio Table 102. Allergan Recent Development Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Weight Loss and Obesity Management Product Image Figure 2. Global Weight Loss and Obesity Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Weight Loss and Obesity Management Market Size (2021-2032) & (US$ Million) Figure 4. Global Weight Loss and Obesity Management Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Weight Loss and Obesity Management Devices Image Figure 8. Weight Loss and Obesity Management Drugs Image Figure 9. Global Weight Loss and Obesity Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Weight Loss and Obesity Management Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Weight Loss and Obesity Management Sales Value Share by Type (2021-2032) Figure 12. Men Image Figure 13. Women Image Figure 14. Global Weight Loss and Obesity Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Weight Loss and Obesity Management Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Weight Loss and Obesity Management Sales Value Share by Application (2021-2032) Figure 17. Global Weight Loss and Obesity Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Weight Loss and Obesity Management Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Weight Loss and Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 20. North America Weight Loss and Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Weight Loss and Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Weight Loss and Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Weight Loss and Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Weight Loss and Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Weight Loss and Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 26. South America Weight Loss and Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Weight Loss and Obesity Management Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Weight Loss and Obesity Management Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Weight Loss and Obesity Management Devices
  • Weight Loss and Obesity Management Drugs
Applications
  • Men
  • Women
Companies covered
  • Eisai
  • Johnson & Johnson
  • Novo Nordisk
  • Medtronic
  • Roche
  • GlaxoSmithKline
  • Vivus Inc
  • ReShape Lifesciences
  • Obalon Therapeutics
  • Nalpropion Pharmaceuticals
  • Beijing Noble Laser Technology
  • Allurion Technologies
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Weight Loss and Obesity Management Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Weight Loss and Obesity Management Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Weight Loss and Obesity Management Market Dynamics
  1. 2.1 Weight Loss and Obesity Management Industry Trends
  2. 2.2 Weight Loss and Obesity Management Industry Drivers
  3. 2.3 Weight Loss and Obesity Management Industry Opportunities and Challenges
  4. 2.4 Weight Loss and Obesity Management Industry Restraints
3 Weight Loss and Obesity Management Market by Company
  1. 3.1 Global Weight Loss and Obesity Management Company Revenue Ranking in 2025
  2. 3.2 Global Weight Loss and Obesity Management Revenue by Company (2021-2026)
  3. 3.3 Global Weight Loss and Obesity Management Company Ranking (2024-2026)
  4. 3.4 Global Weight Loss and Obesity Management Company Manufacturing Base and Headquarters
  5. 3.5 Global Weight Loss and Obesity Management Company Product Type and Application
  6. 3.6 Global Weight Loss and Obesity Management Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Weight Loss and Obesity Management Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Weight Loss and Obesity Management Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Weight Loss and Obesity Management Market by Type
  1. 4.1 Weight Loss and Obesity Management Type Introduction
  2. 4.1.1 Weight Loss and Obesity Management Devices
  3. 4.1.2 Weight Loss and Obesity Management Drugs
  4. 4.2 Global Weight Loss and Obesity Management Sales Value by Type
  5. 4.2.1 Global Weight Loss and Obesity Management Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Weight Loss and Obesity Management Sales Value by Type (2021-2032)
  7. 4.2.3 Global Weight Loss and Obesity Management Sales Value Share by Type (2021-2032)
5 Weight Loss and Obesity Management Market by Application
  1. 5.1 Weight Loss and Obesity Management Application Introduction
  2. 5.1.1 Men
  3. 5.1.2 Women
  4. 5.2 Global Weight Loss and Obesity Management Sales Value by Application
  5. 5.2.1 Global Weight Loss and Obesity Management Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Weight Loss and Obesity Management Sales Value by Application (2021-2032)
  7. 5.2.3 Global Weight Loss and Obesity Management Sales Value Share by Application (2021-2032)
6 Weight Loss and Obesity Management Regional Value Analysis
  1. 6.1 Global Weight Loss and Obesity Management Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Weight Loss and Obesity Management Sales Value by Region (2021-2032)
  3. 6.2.1 Global Weight Loss and Obesity Management Sales Value by Region: 2021-2026
  4. 6.2.2 Global Weight Loss and Obesity Management Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Weight Loss and Obesity Management Sales Value (2021-2032)
  7. 6.3.2 North America Weight Loss and Obesity Management Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Weight Loss and Obesity Management Sales Value (2021-2032)
  10. 6.4.2 Europe Weight Loss and Obesity Management Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Weight Loss and Obesity Management Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Weight Loss and Obesity Management Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Weight Loss and Obesity Management Sales Value (2021-2032)
  16. 6.6.2 South America Weight Loss and Obesity Management Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Weight Loss and Obesity Management Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Weight Loss and Obesity Management Sales Value Share by Country, 2025 VS 2032
7 Weight Loss and Obesity Management Country-level Value Analysis
  1. 7.1 Global Weight Loss and Obesity Management Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Weight Loss and Obesity Management Sales Value by Country (2021-2032)
  3. 7.2.1 Global Weight Loss and Obesity Management Sales Value by Country (2021-2026)
  4. 7.2.2 Global Weight Loss and Obesity Management Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Weight Loss and Obesity Management Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Weight Loss and Obesity Management Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Weight Loss and Obesity Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Weight Loss and Obesity Management Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Weight Loss and Obesity Management Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novo Nordisk
  14. 8.3.1 Novo Nordisk Company Information
  15. 8.3.2 Novo Nordisk Business Overview
  16. 8.3.3 Novo Nordisk Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novo Nordisk Weight Loss and Obesity Management Product Portfolio
  18. 8.3.5 Novo Nordisk Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Weight Loss and Obesity Management Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Weight Loss and Obesity Management Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Weight Loss and Obesity Management Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Vivus Inc
  38. 8.7.1 Vivus Inc Company Information
  39. 8.7.2 Vivus Inc Business Overview
  40. 8.7.3 Vivus Inc Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vivus Inc Weight Loss and Obesity Management Product Portfolio
  42. 8.7.5 Vivus Inc Recent Developments
  43. 8.8 ReShape Lifesciences
  44. 8.8.1 ReShape Lifesciences Company Information
  45. 8.8.2 ReShape Lifesciences Business Overview
  46. 8.8.3 ReShape Lifesciences Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ReShape Lifesciences Weight Loss and Obesity Management Product Portfolio
  48. 8.8.5 ReShape Lifesciences Recent Developments
  49. 8.9 Obalon Therapeutics
  50. 8.9.1 Obalon Therapeutics Company Information
  51. 8.9.2 Obalon Therapeutics Business Overview
  52. 8.9.3 Obalon Therapeutics Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Obalon Therapeutics Weight Loss and Obesity Management Product Portfolio
  54. 8.9.5 Obalon Therapeutics Recent Developments
  55. 8.10 Nalpropion Pharmaceuticals
  56. 8.10.1 Nalpropion Pharmaceuticals Company Information
  57. 8.10.2 Nalpropion Pharmaceuticals Business Overview
  58. 8.10.3 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Product Portfolio
  60. 8.10.5 Nalpropion Pharmaceuticals Recent Developments
  61. 8.11 Beijing Noble Laser Technology
  62. 8.11.1 Beijing Noble Laser Technology Company Information
  63. 8.11.2 Beijing Noble Laser Technology Business Overview
  64. 8.11.3 Beijing Noble Laser Technology Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Noble Laser Technology Weight Loss and Obesity Management Product Portfolio
  66. 8.11.5 Beijing Noble Laser Technology Recent Developments
  67. 8.12 Allurion Technologies
  68. 8.12.1 Allurion Technologies Company Information
  69. 8.12.2 Allurion Technologies Business Overview
  70. 8.12.3 Allurion Technologies Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Allurion Technologies Weight Loss and Obesity Management Product Portfolio
  72. 8.12.5 Allurion Technologies Recent Developments
  73. 8.13 Allergan
  74. 8.13.1 Allergan Company Information
  75. 8.13.2 Allergan Business Overview
  76. 8.13.3 Allergan Weight Loss and Obesity Management Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Allergan Weight Loss and Obesity Management Product Portfolio
  78. 8.13.5 Allergan Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst